Evidence map›Paper›PMID 40497502›Full record

ArticleJournal of the American Heart Association2025

Inpatient Outcomes for Patients With Peripheral Artery Disease Hospitalized for Acute Myocardial Infarction.

Jason Gusdorf, Kamil F Faridi, Tracy Y Wang, Carlos Mena-Hurtado, Kim G Smolderen, Jennifer A Rymer, Jeptha P Curtis, Shuang Li, Eric A Secemsky

Abstract readMulticenter Study
In one paragraph

Article in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jason GusdorfDepartment of Internal Medicine Beth Israel Deaconess Medical Center Boston MA USA.ORCID 0000-0002-4357-5942
Kamil F FaridiSection of Cardiovascular Medicine, Department of Medicine Yale School of Medicine New Haven CT USA.ORCID 0000-0002-9276-9110
Tracy Y WangDuke Clinical Research Institute Durham NC USA.
Carlos Mena-HurtadoSection of Cardiovascular Medicine, Department of Medicine Yale School of Medicine New Haven CT USA.ORCID 0000-0002-4954-5672
Kim G SmolderenSection of Cardiovascular Medicine, Department of Medicine Yale School of Medicine New Haven CT USA.ORCID 0000-0001-6104-6254
Jennifer A RymerDivision of Cardiovascular Medicine, Department of Medicine Duke University School of Medicine Durham NC USA.ORCID 0000-0001-9841-2393
Jeptha P CurtisSection of Cardiovascular Medicine, Department of Medicine Yale School of Medicine New Haven CT USA.ORCID 0000-0002-6872-0501
Shuang LiDuke Clinical Research Institute Durham NC USA.
Eric A SecemskyThe Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiovascular Medicine Beth Israel Deaconess Medical Center Boston MA USA.ORCID 0000-0003-3861-3163

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with both peripheral artery disease (PAD) and coronary artery disease are at heightened risk for adverse cardiovascular outcomes. Although long-term risk has been well documented, contemporary in-hospital outcomes for patients with PAD presenting with acute myocardial infarction (AMI) are less well characterized.

methodsWe analyzed 493 740 AMI hospitalizations from 670 US sites in the NCDR (National Cardiovascular Data Registry) Chest Pain-MI Registry between January 2019 and March 2023. Primary outcomes were in-hospital mortality and major bleeding; secondary end points included cardiac arrest, cardiogenic shock, heart failure, stroke, and new dialysis initiation. Subgroup analyses were conducted by age, sex, race, AMI type, revascularization status, and extent of coronary disease. We used the NCDR validated risk model for multivariable adjustment.

resultsPAD was present in 36 274 patients with AMI (7.4%). In-hospital mortality was significantly higher in patients with PAD compared with those without (8.23% versus 4.87%; adjusted odds ratio [aOR], 1.25 [95% CI, 1.19-1.31]). Increased mortality persisted across age groups (<65 years: aOR, 1.42; ≥65 years: aOR, 1.18) and AMI type (non-ST-segment-elevation MI: aOR, 1.14; ST-segment-elevation MI: aOR, 1.46), with significant interactions by both age and AMI type. Among revascularized patients, mortality was elevated in those with PAD (aOR, 1.49). PAD was associated with increased rates of major bleeding (aOR, 1.23), particularly among revascularized patients (aOR, 1.31), as well as cardiac arrest, shock, heart failure, stroke, and new dialysis.

conclusionsPAD was independently associated with markedly worse in-hospital outcomes in AMI, highlighting the need for risk mitigation strategies in this high-risk population.

Indexed as

HospitalizationInpatientsMyocardial InfarctionPeripheral Arterial DiseaseAgedAged, 80 and overFemaleHemorrhageHospital MortalityHumansMaleMiddle AgedRegistriesRisk AssessmentRisk FactorsUnited StatesatherosclerosisNSTEMIpercutaneous coronary interventionperipheral arterial diseaserevascularizationSTEMI

Identifiers

PMID40497502
PMCPMC12229116

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.